# Study of Pregnancy Outcomes in Women Exposed to Rimegepant During Pregnancy

> **NCT05198245** · — · ACTIVE_NOT_RECRUITING · sponsor: **Pfizer** · enrollment: 1 (estimated)

## Conditions studied

- Migraine

## Interventions

- **DRUG:** Rimegepant
- **DRUG:** Various
- **OTHER:** No intervention

## Key facts

- **NCT ID:** NCT05198245
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-12-15
- **Primary completion:** 2028-04-17
- **Final completion:** 2028-04-17
- **Target enrollment:** 1 (ESTIMATED)
- **Last updated:** 2026-01-08

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05198245

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05198245, "Study of Pregnancy Outcomes in Women Exposed to Rimegepant During Pregnancy". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT05198245. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*